Literature DB >> 2352279

Crystal structure of plakalbumin, a proteolytically nicked form of ovalbumin. Its relationship to the structure of cleaved alpha-1-proteinase inhibitor.

H T Wright1, H X Qian, R Huber.   

Abstract

The crystal structure of plakalbumin, a proteolytically nicked form of ovalbumin, has been determined to a resolution of 2.8 A by the isomorphous replacement method and preliminary refinement. The structure closely resembles that of the cleaved form of alpha-1-proteinase inhibitor, with some important exceptions. The disposition of the new carboxyl chain terminus liberated by proteolysis is different with respect to the central beta-sheet A in the structures of these two molecules. In alpha-1-proteinase inhibitor, the new chain terminus inserts in beta-sheet A to add a middle strand to the sheet. In plakalbumin, this strand remains free near the site at which the cleavage occurs. A structural basis for this difference in behavior is proposed from the structures and sequences of these two molecules and other members of the serpin family. The structures and positions of the putative signal peptide of ovalbumin, the several post-translational modifications, and the relationship of the intron-exon patterns of plakalbumin and alpha-1-proteinase inhibitor to their protein structures are also described.

Mesh:

Substances:

Year:  1990        PMID: 2352279     DOI: 10.1016/s0022-2836(05)80212-8

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  18 in total

1.  Probing the serpin structural-transition mechanism in ovalbumin mutant R339T by proteolytic-cleavage kinetics of the reactive-centre loop.

Authors:  Yasuhiro Arii; Masaaki Hirose
Journal:  Biochem J       Date:  2002-04-15       Impact factor: 3.857

2.  The behavior of R-ovalbumin and its individual components A1, A2, and A3 in urea solution: kinetics and equilibria.

Authors:  Hugh A McKenzie; Robert D Frier
Journal:  J Protein Chem       Date:  2003-04

3.  Serpin alpha 1proteinase inhibitor probed by intrinsic tryptophan fluorescence spectroscopy.

Authors:  H Koloczek; A Banbula; G S Salvesen; J Potempa
Journal:  Protein Sci       Date:  1996-11       Impact factor: 6.725

4.  Comparative study of the interactions between ovalbumin and three alkaloids by spectrofluorimetry.

Authors:  Rui-Qiang Wang; Yu-Jing Yin; Hua Li; Yi Wang; Juan-Juan Pu; Rui Wang; Huan-Jing Dou; Chuan-Jun Song; Rui-Yong Wang
Journal:  Mol Biol Rep       Date:  2012-12-25       Impact factor: 2.316

Review 5.  Inhibitory serpins. New insights into their folding, polymerization, regulation and clearance.

Authors:  Peter G W Gettins; Steven T Olson
Journal:  Biochem J       Date:  2016-08-01       Impact factor: 3.857

6.  S-ovalbumin, an ovalbumin conformer with properties analogous to those of loop-inserted serpins.

Authors:  J A Huntington; P A Patston; P G Gettins
Journal:  Protein Sci       Date:  1995-04       Impact factor: 6.725

7.  Reminiscences from a life in protein physical chemistry.

Authors:  W Kauzmann
Journal:  Protein Sci       Date:  1993-04       Impact factor: 6.725

8.  Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen-VI (187 Asn-->Asp)

Authors:  D Bruce; D J Perry; J Y Borg; R W Carrell; M R Wardell
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

9.  Elucidating the structural chemistry of glycosaminoglycan recognition by protein C inhibitor.

Authors:  L A Kuhn; J H Griffin; C L Fisher; J S Greengard; B N Bouma; F España; J A Tainer
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

10.  The N-terminal domain of antithrombin-III is essential for heparin binding and complex-formation with, but not cleavage by, alpha-thrombin.

Authors:  R C Austin; W P Sheffield; R A Rachubinski; M A Blajchman
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.